Transcription factor decoy: a pre-transcriptional approach for gene downregulation purpose in cancer (Q38300047)

1 September 2017

1 reference

title

Transcription factor decoy: a pre-transcriptional approach for gene downregulation purpose in cancer (English)

1 reference

1 September 2017

author name string

Seyed Mohammad Ali Hosseini Rad

1

1 reference

1 September 2017

Lida Langroudi

2

1 reference

1 September 2017

Fatemeh Kouhkan

3

1 reference

1 September 2017

Laleh Yazdani

4

1 reference

1 September 2017

Alireza Nouri Koupaee

5

1 reference

1 September 2017

Sara Asgharpour

6

1 reference

1 September 2017

Zahra Shojaei

7

1 reference

1 September 2017

Taravat Bamdad

8

1 reference

1 September 2017

Ehsan Arefian

9

1 reference

1 September 2017

publication date

4 April 2015

1 reference

1 September 2017

1 reference

1 September 2017

volume

36

1 reference

1 September 2017

issue

7

1 reference

1 September 2017

page(s)

4871-4881

1 reference

Small dsRNAs induce transcriptional activation in human cells

1 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3344-Z

Activating gene expression in mammalian cells with promoter-targeted duplex RNAs

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3344-Z

Antisense transcripts are targets for activating small RNAs

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3344-Z

RNA activation: promise as a new weapon against cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3344-Z

Double strand RNA-guided endogeneous E-cadherin up-regulation induces the apoptosis and inhibits proliferation of breast carcinoma cells in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3344-Z

Up-regulation of E-cadherin by small activating RNA inhibits cell invasion and migration in 5637 human bladder cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3344-Z

Antitumor effect of dsRNA-induced p21(WAF1/CIP1) gene activation in human bladder cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3344-Z

Prognostic value and function of KLF4 in prostate cancer: RNAa and vector-mediated overexpression identify KLF4 as an inhibitor of tumor cell growth and migration

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3344-Z

Small RNA and transcriptional upregulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3344-Z

Inhibition of Rous sarcoma virus replication and cell transformation by a specific oligodeoxynucleotide

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3344-Z

Randomized phase II study of docetaxel and prednisone with or without OGX-011 in patients with metastatic castration-resistant prostate cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3344-Z

Mipomersen, an apolipoprotein B synthesis inhibitor, for lowering of LDL cholesterol concentrations in patients with homozygous familial hypercholesterolaemia: a randomised, double-blind, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3344-Z

MicroRNA signatures in human cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3344-Z

The Role of microRNAs in Stemness of Cancer Stem Cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3344-Z

Overexpression of microRNA-16 declines cellular growth, proliferation and induces apoptosis in human breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3344-Z

Development of therapeutic splice-switching oligonucleotides.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3344-Z

Therapeutic potential of splice-switching oligonucleotides

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3344-Z

Systemic administration of PRO051 in Duchenne's muscular dystrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3344-Z

Local restoration of dystrophin expression with the morpholino oligomer AVI-4658 in Duchenne muscular dystrophy: a single-blind, placebo-controlled, dose-escalation, proof-of-concept study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3344-Z

The inducible lac operator-repressor system is functional in mammalian cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3344-Z

Expression of a truncated viral trans-activator selectively impedes lytic infection by its cognate virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3344-Z

HIV-1 Gag mutants can dominantly interfere with the replication of the wild-type virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3344-Z

SV40 enhancer-binding factors are required at the establishment but not the maintenance step of enhancer-dependent transcriptional activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3344-Z

Dual blockade of cyclic AMP response element- (CRE) and AP-1-directed transcription by CRE-transcription factor decoy oligonucleotide. gene-specific inhibition of tumor growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3344-Z

Therapeutic applications of transcription factor decoy oligonucleotides

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3344-Z

Genome-wide transcription factor binding: beyond direct target regulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3344-Z

One nucleotide in a kappaB site can determine cofactor specificity for NF-kappaB dimers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3344-Z

Regulation of gene expression with double-stranded phosphorothioate oligonucleotides

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3344-Z

Overexpression of TAR sequences renders cells resistant to human immunodeficiency virus replication

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3344-Z

A gene therapy strategy using a transcription factor decoy of the E2F binding site inhibits smooth muscle proliferation in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3344-Z

Concomitant targeting of multiple key transcription factors effectively disrupts cancer stem cells enriched in side population of human pancreatic cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3344-Z

Transcription factor decoy against stem cells master regulators, Nanog and Oct-4: a possible approach for differentiation therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3344-Z

Use of phosphorothioate-modified oligodeoxynucleotides to inhibit NF-kappaB expression and lymphocyte function

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3344-Z

Application of transcription factor "decoy" strategy as means of gene therapy and study of gene expression in cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3344-Z

Attenuation of interleukin-8 production by inhibiting nuclear factor-kappaB translocation using decoy oligonucleotides

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3344-Z

A double-strand decoy DNA oligomer for NF-kappaB inhibits TNFalpha-induced ICAM-1 expression in sinusoidal endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3344-Z

A single decoy oligodeoxynucleotides targeting multiple oncoproteins produces strong anticancer effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3344-Z

In vivo gene transfer and gene modulation in hypertension research

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3344-Z

Transcription factor decoy oligonucleotide-based therapeutic strategy for renal disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3344-Z

TRED: a transcriptional regulatory element database, new entries and other development

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3344-Z

Cis element 'decoy' against the upstream promoter of the human estrogen receptor gene.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3344-Z

Thioaptamer decoy targeting of AP-1 proteins influences cytokine expression and the outcome of arenavirus infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3344-Z

The use of biosensors for microaffinity purification: an integrated approach to proteomics

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3344-Z

Electrophoretic mobility shift assay (EMSA) for detecting protein-nucleic acid interactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3344-Z

Identification of a novel cyclic AMP-response element (CRE-II) and the role of CREB-1 in the cAMP-induced expression of the survival motor neuron (SMN) gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3344-Z

Biospecific interaction analysis: a tool for drug discovery and development

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3344-Z

Evaluation of the toxicity of ISIS 2302, a phosphorothioate oligonucleotide, in a 4-week study in CD-1 mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3344-Z

Progress in antisense technology: the end of the beginning

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3344-Z

Interaction of the human NF-kappaB p52 transcription factor with DNA-PNA hybrids mimicking the NF-kappaB binding sites of the human immunodeficiency virus type 1 promoter.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3344-Z

Cationic liposomes as delivery systems for double-stranded PNA-DNA chimeras exhibiting decoy activity against NF-kappaB transcription factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3344-Z

Potent and nontoxic antisense oligonucleotides containing locked nucleic acids

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3344-Z

Design and characterization of decoy oligonucleotides containing locked nucleic acids

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3344-Z

NF-kappaB p50 subunit cross-linking to DNA duplexes, containing a monosubstituted pyrophosphate internucleotide bond

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3344-Z

Cell-penetrating peptides.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3344-Z

The taming of the cell penetrating domain of the HIV Tat: myths and realities

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3344-Z

TP10, a delivery vector for decoy oligonucleotides targeting the Myc protein.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3344-Z

Encapsulation of NF-kappaB decoy oligonucleotides within echogenic liposomes and ultrasound-triggered release

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3344-Z

Cell type-specific delivery of siRNAs with aptamer-siRNA chimeras

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3344-Z

Transvascular delivery of small interfering RNA to the central nervous system.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3344-Z

Delivery of siRNA to the mouse brain by systemic injection of targeted exosomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3344-Z

Cequent Pharmaceuticals, Inc.: the biological pitcher for RNAi therapeutics.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3344-Z

Short hairpin RNA-expressing bacteria elicit RNA interference in mammals

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3344-Z

Bacterially derived 400 nm particles for encapsulation and cancer cell targeting of chemotherapeutics

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3344-Z

In vivo delivery of RNAi with lipid-based nanoparticles

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3344-Z

Antisense therapy for cancer--the time of truth

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3344-Z

Oligonucleotides as anticancer agents: from the benchside to the clinic and beyond

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3344-Z

Inhibition of inducible NF-kappaB activity reduces chemoresistance to 5-fluorouracil in human stomach cancer cell line

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3344-Z

Inhibitory effect of nuclear factor-κB decoy oligodeoxynucleotide on liver fibrosis through regulation of the epithelial-mesenchymal transition

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3344-Z

Targeted inhibition of Stat3 with a decoy oligonucleotide abrogates head and neck cancer cell growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3344-Z

Blockage of STAT3 signaling pathway with a decoy oligodeoxynucleotide inhibits growth of human ovarian cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3344-Z

Therapeutic effects of STAT3 decoy oligodeoxynucleotide on human lung cancer in xenograft mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3344-Z

Targeting blockage of STAT3 in hepatocellular carcinoma cells augments NK cell functions via reverse hepatocellular carcinoma-induced immune suppression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3344-Z

Deactivation of signal transducer and activator of transcription 3 reverses chemotherapeutics resistance of leukemia cells via down-regulating P-gp

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3344-Z

E2F decoy oligodeoxynucleotides effectively inhibit growth of human tumor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3344-Z

Apoptosis, growth arrest and suppression of invasiveness by CRE-decoy oligonucleotide in ovarian cancer cells: protein kinase A downregulation and cytoplasmic export of CRE-binding proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3344-Z

Downregulation of TNF-alpha and VEGF expression by Sp1 decoy oligodeoxynucleotides in mouse melanoma tumor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3344-Z

G4-DNA formation in the HRAS promoter and rational design of decoy oligonucleotides for cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3344-Z

Adeno-associated virus-mediated cancer gene therapy: current status

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3344-Z

Retrovirus and lentivirus vector design and methods of cell conditioning

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3344-Z

RNAi-mediated gene silencing in non-human primates.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3344-Z

Lipid-like materials for low-dose, in vivo gene silencing

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3344-Z

Exosomes: Fit to deliver small RNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3344-Z

Lac repressor can regulate expression from a hybrid SV40 early promoter containing a lac operator in animal cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3344-Z

Chromatin immunoprecipitation (ChIP).

21 January 2018

1 reference

12 December 2020

HIF-1α decoy oligodeoxynucleotides inhibit HIF-1α signaling and breast cancer proliferation.

1 reference

12 December 2020

Cell-penetrating peptides: application in vaccine delivery

1 reference

12 December 2020

Oligodeoxynucleoside phosphorothioate stability in subcellular extracts, culture media, sera and cerebrospinal fluid

1 reference

12 December 2020

Role of retinoblastoma protein and E2F-1 transcription factor in the acquisition of 5-fluorouracil resistance by colon cancer cells.

1 reference

12 December 2020

Biospecific interaction analysis (BIA) of low-molecular weight DNA-binding drugs.

1 reference

12 December 2020

Transfection of NF-kappaB decoy oligodeoxynucleotides into macrophages reduces murine fatal liver failure after excessive hepatectomy

1 reference

12 December 2020

Antibody mediated in vivo delivery of small interfering RNAs via cell-surface receptors

1 reference

12 December 2020

Viral vectors for gene transfer: current status of gene therapeutics

1 reference

12 December 2020

Basic principles of using antisense oligonucleotides in vivo

1 reference

12 December 2020

Inhibitory effects of STAT3 decoy oligodeoxynucleotides on human epithelial ovarian cancer cell growth in vivo

1 reference

12 December 2020

Activation of the alternative pathway of complement by a phosphorothioate oligonucleotide: potential mechanism of action.

1 reference

12 December 2020

Attenuation of lung injury in allograft rejection using NF-kappaB decoy transfection-novel strategy for use in lung transplantation

1 reference

12 December 2020

10.1007/S13277-015-3344-Z

Identifiers

DOI

1 reference

Dimensions Publication ID

1 September 2017

1031912443

0 references

1 reference